DYNTQ · DYNATRONICS CORP · Financials
$0.00
At close · Apr 30
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 19, 2025
Substantial doubt about the company's ability to continue as a going concern.
“The Company's declining revenues, recurring operating losses and negative cash flows, and continued reduction in liquidity, raise substantial doubt about the Company's ability to continue as a going concern within one year after the issuance date of these condensed consolidated financial statements. The Company believes that if it successfully implements the foregoing strategic actions, it has a chance to mitigate the factors giving rise to substantial doubt; however, there is no guarantee that it will successfully implement these strategic actions. As a result, substantial doubt remains regarding the Company's ability to continue as a going concern.”View the 10-Q filed Nov 19, 2025
Market Cap
$653,183
Shares
16.05M
Volume · Apr 30
296
Avg daily vol (3M)
13.54K
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$27.39M
-15.8%
FY2025
Net Income
-$10.9M
-304.1%
FY2025
Gross Margin
21.94%
-1.5pp
FY2025
Operating Margin
-8.96%
-2pp
FY2025
Diluted EPS
-$1.43
-43%
FY2025
Operating Cash Flow
$300.58K
+118.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $26.81M | $27.39M | $32.53MG | $40.61MG | $44.34M | $47.8M | $53.41M | $62.57M | $64.41M | $35.76M | $30.41M | $29.12M | $27.44M | $29.54M | $31.66M | $32.69M | |
| $21.05M | $21.38M | $24.9M | $30.46M | $33.67M | $34.91M | $38.31M | $43.39M | $43.99M | $24.25M | $20.06M | $20.05M | $17.42M | $18.45M | $19.72M | $20.21M | |
| $5.76M | $6.01M | $7.63M | $10.15M | $10.67M | $12.89M | $15.1M | $19.17M | $20.42M | $11.51M | $10.35M | $9.07M | $10.02M | $11.09M | $11.94M | $12.48M | |
| — | 21.94% | 23.47% | 24.99% | 24.07% | 26.96% | 28.27% | 30.65% | 31.7% | 32.18% | 34.05% | 31.15% | 36.51% | 37.53% | 37.72% | 38.19% | |
| — | — | — | — | — | $10K | $95K | $54K | $1.19M | $1.08M | $1.07M | $926.95K | $992.73K | $1.12M | $1.41M | $1.38M | |
| $8.05M | $8.46M | $9.91M | $15M | $15.43M | $16.65M | $18.09M | $19.97M | $21.67M | $12.1M | $10.98M | $9.23M | $9.21M | $9.86M | $10.51M | $10.43M | |
| $567.67K | $618.3K | $618.3K | $622.45K | $688.15K | $754.12K | $724.38K | $724.38K | -$638.36K | -$95.01K | -$30.68K | -$44.64K | -$96.53K | $44.64K | $44.64K | $83.21K | |
| $439.97K | $487.01K | $685.41K | $726.39K | $733.65K | $852.67K | $1.01M | $887.01K | -$673.57K | -$242.54K | -$229.93K | -$350.96K | -$433.01K | -$435.37K | -$404.37K | $370.73K | |
| -$2.29M | -$2.45M | -$2.27M | -$4.85M | -$4.76M | -$3.76M | -$2.99M | -$796.1K | -$1.25M | -$1.67M | -$1.69M | -$1.09M | -$185.79K | $104.75K | $26.37K | $669.65K | |
| — | -8.96% | -6.99% | -11.95% | -10.73% | -7.87% | -5.6% | -1.27% | -1.94% | -4.68% | -5.57% | -3.73% | -0.68% | 0.35% | 0.08% | 2.05% | |
| -$1.85M | -$1.97M | -$1.59M | -$4.13M | -$4.02M | -$2.91M | -$1.98M | $90.92K | -$1.92M | -$1.92M | -$1.92M | -$1.44M | -$618.8K | -$330.62K | -$378.01K | $1.04M | |
| $406.92K | $409.91K | $418.01K | $118.31K | $147.99K | $215.63K | $435.61K | $512.19K | -$428.46K | -$277.63K | -$289.15K | -$330.84K | -$231.87K | -$260.7K | -$261.99K | -$294.4K | |
| — | — | — | — | — | — | — | — | — | $508 | $2885 | $4920 | $44 | $681 | $16.18K | $16.4K | |
| -$8.43M | -$8.44M | -$424.67K | -$121.71K | $763.01K | $5.75M | -$442.39K | -$120.15K | — | — | — | — | -$211.38K | -$235.88K | -$216.61K | -$250.79K | |
| -$10.72M | -$10.89M | -$2.7M | -$4.97M | -$3.99M | $1.99M | -$3.44M | -$916.25K | -$1.67M | -$1.87M | -$1.97M | -$1.4M | -$397.17K | -$131.13K | -$190.24K | $418.86K | |
| $12.89K | $12.16K | $0 | $0 | $0 | $9982 | -$10.07K | $5474 | $70.31K | $0 | $64.55K | $851.09K | -$126.02K | -$86.75K | -$166.71K | $147.98K | |
| -$10.74M | -$10.9M | -$2.7M | -$4.97M | -$3.99M | $2M | -$3.43M | -$921.72K | -$1.6M | -$1.87M | -$1.9M | -$2.25M | -$271.14K | -$44.37K | -$23.54K | $270.89K | |
| — | -39.8% | -8.29% | -12.25% | -9.01% | 4.19% | -6.41% | -1.47% | -2.49% | -5.22% | -6.26% | -7.73% | -0.99% | -0.15% | -0.07% | 0.83% | |
| -$11.45M | -$11.6M | -$3.43M | -$5.66M | -$4.73M | $1.21M | -$4.32M | -$1.72M | -$3.5M | -$4.29M | -$2.27M | -$5.11M | -$271.14K | — | — | — | |
| USD/shares | -$1.37 | -$1.43 | -$1.00 | -$1.46 | -$1.32 | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | -$1.37 | -$1.43 | -$1.00 | -$1.46 | -$1.32 | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 8.13M | 3.42M | 3.87M | 3.57M | 15.46M | 10.26M | 8.25M | 6.62M | 3.15M | 2.71M | 2.52M | 2.52M | 2.53M | 2.56M | 13.33M |
| shares | — | 8.13M | 3.42M | 3.87M | 3.57M | 15.46M | 10.26M | 8.25M | 6.62M | 3.15M | 2.71M | 2.52M | 2.52M | 2.53M | 2.56M | 13.37M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2011–FY2013: $1.02M in buybacks.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current finance lease liabilities | 2025-09-30 | USD 324,933 | 10-Q filed 2025-11-19 |
| Current operating lease liabilities | 2025-09-30 | USD 1,057,991 | 10-Q filed 2025-11-19 |
| Noncurrent finance lease liabilities | 2025-09-30 | USD 1,025,503 | 10-Q filed 2025-11-19 |
| Noncurrent operating lease liabilities | 2025-09-30 | USD 1,889,848 | 10-Q filed 2025-11-19 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Physical Therapy and Rehabilitation Products | $15,154,800 | $16,395,499 | $22,056,592 | $23,196,669 | $26,912,594 |
| Orthopedic Soft Bracing Products | $12,144,198 | $16,055,785 | $18,450,062 | $21,033,599 | $20,630,171 |
| Other Products | $94,165 | $82,681 | $102,718 | $108,222 | — |